© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
381883 |
As an accredited 2,6-Dibromo-3-Hydroxypyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2,6-Dibromo-3-Hydroxypyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Over the years, I’ve noticed that some compounds tend to slip through the cracks in terms of recognition, even while they shape truly crucial advances behind the scenes. 2,6-Dibromo-3-hydroxypyridine is one of these. If you’re unfamiliar, this pyridine derivative draws attention not for being a commodity chemical, but for how it empowers specific transformations in pharmaceutical and agrochemical laboratories. Ask any chemist tinkering with halogenated heterocycles, and they’ll mention the drive for compounds that lend themselves to selective halogenation without corrupting the functional core. This molecule sits in that narrow margin where selectivity, purity, and reactivity all come together.
In practice, 2,6-dibromo-3-hydroxypyridine combines a pyridine ring system, two bromine atoms at the 2 and 6 positions, plus a hydroxy group at the 3-position. The key here isn’t just where the atoms attach, but the character they bring to the table. Those bromines don’t simply act as obstacles to further modification; they create windows for chemists aiming for cross-coupling or halogen-exchange reactions. Many times, someone eager to create a new kinase inhibitor or crop protection agent realizes that positional selectivity is half the battle. This is where dibromo-3-hydroxypyridine has become a preference, especially when compared to more arbitrarily brominated pyridines.
Let’s be honest: plenty of halogenated pyridines exist on the market. Enthusiasts may point to 2,6-dibromopyridine or even less-substituted options. So why do researchers in both industrial and university settings seek out this specific model—CAS 66790-18-5—of 2,6-dibromo-3-hydroxypyridine? Based on direct experience, the difference often comes down to the outcome of downstream reactions. The -OH at the 3-position doesn’t just sit there; it spins open the door for forming ether or ester derivatives. It also impacts the electron density of the pyridine ring, affecting reactivity in ways that plain dibromopyridine can’t replicate. This edge is more than theoretical—yield improvements and purification ease show up when the right starting material is in play.
One struggle in synthetic chemistry involves the drag from poorly reacting substrates. Using the right precursor unblocks a whole route. Labs focused on nucleophilic substitutions or Suzuki-type couplings often hinge their process development on the characteristics of their starting heterocycle. In this environment, dibromo-3-hydroxypyridine can outperform simpler analogues. Its bromo substituents act as handles for well-established cross-coupling chemistry, while the hydroxy group can serve as a lever for further functionalization. That means you can go from a simple feedstock to a custom aryl ether, or protect the -OH and explore new substitution patterns. In my time tracking research output, such flexibility has repeatedly opened doors for rapidly changing project goals.
Comparison to other brominated pyridines makes sense. For instance, researchers regularly contrast 2,6-dibromo-3-hydroxypyridine’s behavior with that of 2,6-dibromopyridine or 3-hydroxy-2-chloropyridine. The hydroxy group acts as both an activator and a functional handle, shifting electron density enough to boost nucleophilic substitution, making this material preferable for complex routes. For teams working on unexplored arylation chemistry, having a defined hydroxy group on the pyridine ring shifts the selectivity in ways that can't always be duplicated with other halogen patterns. In one example, colleagues in a process chemistry group aimed to access a library of substituted quinolines. The dibromo-3-hydroxy arrangement helped simplify their path, sparing weeks of troubleshooting.
I’ve noticed over time that consistency in the material’s quality always impacts experimental success. Unlike commonly sold grades, which vary in purity and may hold moisture or trace metal contaminants, well-specified 2,6-dibromo-3-hydroxypyridine provides confidence in reproducibility. Modern analytical labs expect purity above 98 percent for their research purposes, confirmed by HPLC, NMR, and possibly mass spectrometry. Impurities at brominated positions can throw synthetic outcomes; they tend to result in product mixtures or loss of yield. Having pure product allows R&D chemists to spend less time troubleshooting and more time exploring new reaction conditions or analogs. With other pyridine derivatives, process variation between suppliers sometimes means rerunning purification steps, but my experience with this compound points to less downtime and more useful chemistry.
The journey from simple chemicals to high-value pharmaceuticals or crop protection compounds rarely allows shortcuts. Every intermediate needs to be consistent, versatile, and robust. In the context of making arylated pyridine-based drugs, a single impurity or poor leaving group can derail efficiency. This is where dibromo-3-hydroxypyridine has proven itself. Its structure lends itself to a wider palette of transformations. For instance, research teams working on kinase inhibitors recognized that installing diverse functionalities on the pyridine core relies heavily on reliable handles—the bromines provide this, while the hydroxy group makes selective transformation more convenient. Over time, such intermediate choices have ripple effects through scale-up and regulatory processes, because fewer impurities or byproducts downstream mean simpler purification in the final product.
It’s tempting to assume heterocyclic compounds like this only shine in pharma, but the impact stretches into agricultural chemistry as well. Heteroatom-containing aromatics such as pyridines routinely form the backbone of herbicides and fungicides. Here, 2,6-dibromo-3-hydroxypyridine provides distinct value due to the balance of reactivity and selectivity inherent in its substitution pattern. Formulators look for ways to tweak base molecules to dial in potency or environmental fate. The hydroxy-bromo arrangement helps with that. I've seen teams exploit this structure to generate analogs that degrade at different rates in soil, or bind differently to plant enzymes, expanding control over persistence and efficacy. Materials scientists, meanwhile, pick up on the bromine atoms as points for further modification, aiming to integrate small molecules into polymers or other frameworks where other substitution patterns just don’t fit as well.
Those delving into the economics of specialty chemical use know the landscape changes all the time. Price and availability have as much impact as reactivity. Because this compound involves both bromination and precise positioning, sourcing reliable material often becomes a block for smaller labs or companies. Over the years, global supply chains have become both asset and risk. Chinese manufacturers reached strong scale, but quality sometimes drifts without consistent oversight. Meanwhile, select European or American labs offer smaller batches with tighter controls, at a premium. Each customer—academic or industrial—weighs the tradeoff. From my own experience, communicating standards and analytical requirements up front with suppliers sidesteps many future surprises. The best outcomes come when specifications match the end-use: general screening may not demand the same grade needed for a pharma intermediate heading to regulatory approval.
No discussion of modern chemistry sidesteps questions of safety and sustainability. Brominated organics, including dibromo-hydroxypyridine, pose real handling and environmental considerations. These aren’t frivolous concerns. Some byproducts, if mishandled, risk lingering in the environment or resisting breakdown. Labs and commercial processors rely on comprehensive risk assessments, appropriate ventilation, and effective personal protection protocols. Disposal of waste or leftover starting material aligns with stricter regulatory controls every year. I remember a time in the late 2000s when guidelines were patchier; now, expectations from buyers and regulators have caught up. Aligning purchasing choices with suppliers who also take these issues seriously adds another safeguard. For those scaling from grams to kilos, waste minimization and solvent management grow in importance, affecting not just cost but community safety as well.
Looking toward advancing technologies, the range of uses for dibromo-3-hydroxypyridine keeps expanding. Automation in combinatorial chemistry takes advantage of its predictable reactivity patterns, making it a mainstay for exploratory libraries of bioactive small molecules. AI-driven molecular design continues to propose new functionalizations on pyridine rings, many of which call for selective halogen handles and functional groups that allow rapid diversification. The design flexibility of the hydroxy-bromo combination allows chemists to introduce polar or nonpolar fragments, adjust solubility, and fine-tune bioavailability in candidate compounds. Feedback from early adopters of robotic synthesis platforms shows this compound plugging gaps where other halogenated pyridines stall out.
Young researchers entering the lab for the first time learn quickly that success in synthesis isn’t just about ambition. The choice of starting materials either accelerates discovery or sets up weeks of frustration. Many academic labs now include 2,6-dibromo-3-hydroxypyridine in their standard heterocycle toolkit, leaning on its reliability. This speeds up access to advanced intermediates, especially in course-based labs or undergraduate research settings. The transparency of reaction pathways when using such clear-cut molecules serves as a strong teaching aid, showing newer chemists how to interpret NMR, plan protection-deprotection steps, and predict outcomes. It also demystifies the challenge of multi-step synthesis, which can otherwise appear daunting to the uninitiated.
Some seasoned chemists raise concerns about sourcing, price flux, or the potential for raw material shortages as demand shifts. This context can create uncertainty for longer-term projects or commercial supply chains. Efforts are underway across some producers to optimize synthetic routes—moving away from expensive or hazardous reagents and toward greener, safer alternatives. I’ve seen several academic collaborations focused on inventing catalytic methods to introduce bromines at the required alpha positions without resorting to harsh conditions, which could improve both environmental footprint and market stability. Encouragement for open communication between users and producers may soon result in broader adoption of green chemistry principles in large-scale production. As the ecological impact of brominated aromatics comes under even more scrutiny, there will be a stronger push for effective waste treatment, lower-emission processes, and recyclable solvents.
Hard data often tells the real story. In recent years, documentation from elite pharmaceutical R&D groups points to stepwise improvements in yield and purity when swapping in 2,6-dibromo-3-hydroxypyridine over older, less functionalized scaffolds. Representative cases involve late-stage diversification of core molecules—adding ether, amide, or aryl linkers—without drifting into unknown side reactions. In agrochemical development programs, iterative analog synthesis proves faster. Since bromine atoms direct further borylation or coupling chemistry, and the hydroxy group can join in hydrogen-bonding interactions, countless structure-activity relationships receive clarification more quickly. Analytical labs confirm higher selectivity during chromatography and less waste during cleanup. None of these advances are accidental; smart intermediate choice repeatedly demonstrates practical gains over time.
Budget management always drags on priority project lists, regardless of industry. Acquiring specialized building blocks like dibromo-3-hydroxypyridine sometimes presents a challenge, particularly for smaller groups or academic consortia. That said, a pragmatic approach—building direct relationships with reliable suppliers and requesting up-to-date certificates of analysis—usually saves headaches down the road. Teams planning longer project timescales look to validate each batch upon arrival, rather than relying on old certificates. It might seem tedious, but this kind of diligence reduces repeat errors. Engaging with suppliers over analytic requirements or even trace impurity testing can convert a supplier into a trusted partner, which matters when regulators circle back years later to scrutinize precursor quality.
As regulations tighten in both pharmaceuticals and agriculture, thorough documentation for every intermediate gains importance. Regulatory filings expect to see full traceability for source, purity, and handling. Organizations producing drugs or crop control agents need transparent supply chains and full documentation at every stage. This environment nudges end users toward suppliers with comprehensive testing, change notifications, and a track record of batch consistency, circling back to the original point: the value of quality in 2,6-dibromo-3-hydroxypyridine isn’t only technical, but administrative as well. Lapses in paperwork can delay launches or lead to missed filings. Providers aware of global regulatory expectations working in tandem with clients ensure less risk of costly setbacks during late-stage product registration.
Having seen multiple procurement cycles, I’ve recognized the most commonly overlooked factors don’t involve specs on a data sheet, but rather nuances of reactivity under real-world lab conditions. For example, ambient storage humidity can influence the hydroxy group’s behavior over time, with some batches picking up trace water content. This small change can alter reaction outcomes, particularly in moisture-sensitive couplings or protection-deprotection schemes. Users who monitor physical characteristics—color, melting range, and appearance—alongside certificate-stated purity tend to experience fewer surprises. Prompt feedback to suppliers about even minor changes in product appearance supports a more transparent and reliable supply chain.
For chemists in the trenches, the real test comes on the synthesis bench. Their needs balance between high purity and manageable cost. From the procurement side, the main challenge involves triangulating between price, batch size, shipping risk, and delivery time. I've watched as procurement teams gained a stronger grasp of technical priorities by including R&D in supplier conversations. This cross-talk allows for better batch reservation planning, proactive identification of supply chain bottlenecks, and more realistic delivery timelines, particularly around global holidays or raw material shortages. A unified approach means nobody gets left scrambling for critical precursors or takes shortcuts on quality.
Synthetic organic chemistry pushes compound libraries ever wider, diving into untapped reactivity with traditional heterocycles. Increasingly, research groups build novel frameworks by leveraging the unique bromo-hydroxy pattern of this pyridine. Pd-catalyzed cross-couplings remain dependable, while photoredox and nickel-catalyzed routes tap into the potential offered by these specific substituents. For those in drug discovery or diagnostics, rapid SAR profiling grows easier. With stronger automation and machine learning guiding molecular design, compounds like 2,6-dibromo-3-hydroxypyridine play critical roles as versatile, predictable building blocks, supporting rapid iteration and scale-up. Real progress traces back to the interplay between structural novelty and reliable supply of complex intermediates like these.
As chemical practice continues to evolve, ongoing improvement in both environmental performance and supply resilience stands out as the next big challenge. Several efforts—ranging from solvent recycling programs, process intensification, cataloguing greener reagents—point toward reduced footprint and less toxic byproduct formation. Investing in greener routes for pyridine halogenation and in process-scale hydroxy group installation could soften the legacy impact of brominated aromatics. Buyers with a stake in the full life cycle of their compounds tend to favor suppliers rolling out green chemistry commitments, aligning downstream partners with safer, more sustainable standards. Anticipating further regulatory and consumer pressure, companies and research groups that plan for these changes early often find themselves ahead of mandates and competitors.
To sum up years of working in and around specialty chemical supply and application: 2,6-dibromo-3-hydroxypyridine represents more than just another building block. Its unique blend of selective reactivity and practical synthesis utility bridges crucial gaps for both novice and expert chemists. Decision-makers who stay proactive—vetting suppliers, monitoring trends in quality, syncing project timelines with supply—reap the benefits of fewer disruptions and more flexibility in their research or manufacturing cycles. So as the market and regulatory environment steer toward greater responsibility and efficiency, those who choose robust, reliable intermediates like dibromo-3-hydroxypyridine help shape safer, more innovative, and ultimately more productive lab and industrial practice.
